We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Shareholding and Issue of Equity

7 Jan 2016 15:21

RNS Number : 1966L
Tungsten Corporation PLC
07 January 2016
 

TUNGSTEN CORPORATION PLC

 

("Tungsten" or the "Company")

 

 

For Immediate Release

 

7 January 2016

 

Director's Shareholding and Issue of Equity

 

Tungsten has today issued and allotted 664,000 ordinary shares of 0.438 pence each in the capital of the Company ("Ordinary Shares") to Richard Hurwitz, the Company's Chief Executive Officer. Mr Hurwitz was awarded the new Ordinary Shares pursuant to the terms of his service agreement put in place following his appointment as the Company's Chief Executive Officer in July 2015. Mr Hurwitz's beneficial interest following this transaction is now in 664,000 Ordinary Shares, representing 0.5% of the Company's issued share capital.

 

The Company has also been informed that Nicholas Parker, Chairman, has today purchased 100,000 Ordinary Shares into his SIPP at a price of 39.75 pence per share. Mr Parker's resultant beneficial interest is now in 221,250 Ordinary Shares, representing 0.2% of the Company's issued share capital.

 

Application will be made for the admission of 664,000 new Ordinary Shares to trading on AIM. It is expected that admission will become effective and dealings will commence in the new Ordinary Shares on 13 January 2016.

 

On admission to trading of the 664,000 new Ordinary Shares, the Company will have 126,068,397 Ordinary Shares in issue with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

 

Enquiries:

 

Tungsten Corporation plc

Chaz Sarathchandra, Communications Manager

+44 20 7280 6983

Panmure Gordon (Nominated Adviser)

Fred Walsh / Dugald J. Carlean

+44 20 7886 2500

 

Canaccord Genuity Limited (Broker)

Simon Bridges/Emma Gabriel/Cameron Duncan

+44 20 7523 8000

 

Neustria Partners (Investors and Analysts)

Robert Bailhache/Nick Henderson/Charles Gorman

+44 20 3021 2580

 

 

About Tungsten Corporation plcTungsten Corporation (LSE: TUNG) accelerates global trade by enabling customers to streamline invoice processing, improve cash-flow management and make better buying decisions from their detailed spend data.

 

Buyer organisations that join Tungsten Network, the world's largest compliant electronic invoicing network, can reduce their invoice-processing costs by 60%. Suppliers benefit from efficiencies, greater visibility of their invoice status and peace of mind. Tungsten offers options for supply chain financing and helps buying organisations profit by applying real-time spend analytics to its vast repository of line-level invoice data.

 

Tungsten serves 56% of the Fortune 500 and 67% of the FTSE 100 by connecting the world's largest companies and government agencies to their thousands of suppliers around the globe. It enables suppliers to submit tax compliant e-Invoices in 47 countries, and last year processed transactions worth over $187bn for organisations such as Alliance Data, Aviva, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg's, and the US Federal Government.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUBGGUPQGAM
Date   Source Headline
23rd Mar 20212:15 pmRNSCustomer Loss
17th Mar 20214:35 pmRNSPrice Monitoring Extension
16th Mar 20214:40 pmRNSSecond Price Monitoring Extn
16th Mar 20214:36 pmRNSPrice Monitoring Extension
12th Feb 20217:00 amEQSTungsten (TUNG): Foundations for growth in place
19th Jan 20214:15 pmRNSHolding(s) in Company
19th Jan 20214:10 pmRNSHolding(s) in Company
15th Jan 20214:36 pmRNSPrice Monitoring Extension
6th Jan 202111:00 amRNSHolding(s) in Company
4th Jan 20217:00 amRNSHolding(s) in Company
18th Dec 20204:30 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSInterim Results
11th Dec 20207:00 amRNSNew Customer Win
10th Dec 20201:05 pmRNSHolding(s) in Company
1st Dec 20204:40 pmRNSSecond Price Monitoring Extn
1st Dec 20204:35 pmRNSPrice Monitoring Extension
27th Nov 20207:00 amRNSTrading Update
2nd Nov 20204:31 pmRNSAdditional Listing and Total Voting Rights
2nd Nov 20204:30 pmRNSDirector/PDMR Shareholding
23rd Oct 20201:05 pmRNSHolding(s) in Company
20th Oct 20207:00 amRNSAppointment of Non-Executive Director
16th Oct 20203:50 pmRNSResult of AGM
15th Oct 20205:49 pmRNSAdditional Listing and TVR
2nd Oct 20207:00 amRNSAdditional Listing and Total Voting Rights
23rd Sep 20207:00 amRNSBlock Listing Application
15th Sep 202012:30 pmRNSHolding(s) in Company
11th Sep 20207:00 amRNSDirectorate Change
9th Sep 20207:00 amRNSHolding(s) in Company
7th Sep 20207:00 amRNSFinal Results
20th Jul 20207:00 amRNSTrading Update
2nd Jul 20201:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSReporting Timetable
17th Apr 20207:00 amRNSAppointment of Chief Financial Officer
3rd Apr 202012:05 pmRNSDirector/PDMR Share Dealing
2nd Apr 20202:15 pmRNSDirector/PDMR Share Dealing
31st Mar 20201:40 pmRNSAppointment of Non Executive Director
31st Mar 202012:07 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 202011:16 amRNSChange of Nominated Adviser
23rd Mar 20207:00 amRNSCOVID-19 Update
19th Mar 202011:45 amRNSDirector/PDMR Share Dealing
16th Mar 20201:15 pmRNSHolding(s) in Company
10th Mar 20207:00 amRNSTrading Update for the Nine Months to 31 Jan 2020
6th Mar 202012:07 pmRNSSecond Price Monitoring Extn
6th Mar 202012:02 pmRNSPrice Monitoring Extension
5th Feb 20202:46 pmRNSDIRECTORATE CHANGE UPDATE
4th Feb 20204:40 pmRNSSecond Price Monitoring Extn
4th Feb 20204:35 pmRNSPrice Monitoring Extension
22nd Jan 20207:00 amRNSDIRECTORATE CHANGE
10th Jan 20204:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.